SUNHO BIO-B (02898) announced its interim performance, with a net loss of 38.199 million yuan, a year-on-year increase of 5.88%.

date
29/08/2025
avatar
GMT Eight
Shenghe Biotech-B (02898) announces its mid-term performance for 2025, with other income of 5.035 million yuan, a year-on-year growth of...
SUNHO BIO-B(02898) announced its mid-term performance for 2025, with other income of 5.035 million yuan, a year-on-year increase of 182.55%; a net loss of 38.199 million yuan, a year-on-year increase of 5.88%; and a loss per share of 0.25 yuan.